Our Chief Policy and Partnerships Officer, Richard Gold, argues that Canada has a unique opportunity to become a global leader in AI-assisted drug discovery by leveraging its strong scientific expertise and biomedical data infrastructure. To reduce reliance on the U.S., Canada must invest in large, open datasets, streamline regulations, and foster collaboration between government, academia, and industry—positioning itself as a key hub for innovation in drug development.
Read this article in The National Observer »
Richard also recently appeared on TVO and on CBC’s The Current, sharing his expertise on similar topics. Follow the links below to watch and listen to the interviews.
Watch on TVO: Could American’s Brain Drain Be Canada’s Brain Gain? »
